Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation

Published:2016-12-28 Issue:1 Volume:19 Page:e12629
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Slade Michael¹^ORCID,Goldsmith Scott¹,Romee Rizwan²,DiPersio John F.²,Dubberke Erik R.³,Westervelt Peter²,Uy Geoffrey L.²,Lawrence Steven J.³

Affiliation:

1. Department of Medicine; Washington University School of Medicine; Saint Louis MO USA

2. Division of Oncology; Washington University School of Medicine; Saint Louis MO USA

3. Division of Infectious Diseases; Washington University School of Medicine; Saint Louis MO USA

Funder

National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12629/fullpdf

Reference33 articles.

1. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation;Bashey;J Clin Oncol,2013

2. Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia;Ciurea;Blood,2015

3. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts;Raiola;Biol Blood Marrow Transplant,2014

4. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transpl,2008

5. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide;Castagna;Biol Blood Marrow Transplant,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients;Blood Advances;2024-09-10

2. Preneutropenic Fever in Patients With Hematological Malignancies: A Novel Target for Antimicrobial Stewardship;Open Forum Infectious Diseases;2024-08-27

3. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients;Expert Opinion on Biological Therapy;2024-03-03

4. Comparison of Infectious Complications in Patients Receiving High-Dose Cyclophosphamide as GvHD After Transplantation From A 9/10 HLA-Matched Unrelated Donor with Standard GvHD Prophylaxis After Transplant From A Full Matching Donor;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

5. Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft;Transplantation and Cellular Therapy;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3